On 2023-08-14, RVL Pharmaceuticals PLC (RVLP) announced earnings per share of $-0.13 for the fiscal quarter ending 2023-06-30, meeting the average analyst estimate of $-0.13.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-08-14 | 2023-06-30 | $-0.13 | $-0.13 |
| 2023-05-11 | 2023-03-31 | $-0.12 | $-0.12 |
| 2023-03-20 | 2022-12-31 | $-0.15 | $-0.18 |
| 2022-11-10 | 2022-09-30 | $-0.19 | $-0.16 |
| 2022-08-11 | 2022-06-30 | $-0.24 | $-0.19 |
| 2022-05-12 | 2022-03-31 | $-0.25 | $-0.13 |
| 2022-03-30 | 2021-12-31 | $-0.29 | $-0.26 |
| 2021-11-15 | 2021-09-30 | $-0.36 | $-0.42 |
| 2021-08-16 | 2021-06-30 | $-0.15 | $-0.15 |
| 2021-05-13 | 2021-03-31 | $-0.23 | $-0.15 |
| 2021-03-30 | 2020-12-31 | $-0.16 | $-0.26 |
| 2020-11-10 | 2020-09-30 | $-0.20 | $-0.14 |
| 2020-08-11 | 2020-06-30 | $-0.16 | $-0.16 |
| 2020-05-12 | 2020-03-31 | $-0.12 | $-0.05 |
| 2020-03-18 | 2019-12-31 | $0.01 | $0.06 |
| 2019-11-14 | 2019-09-30 | $-0.30 | $-0.22 |
| 2019-08-08 | 2019-06-30 | $-0.04 | $0.02 |
| 2019-05-09 | 2019-03-31 | $-0.04 | $-0.12 |
| 2018-11-08 | 2018-09-30 | -- | $-4.99 |